These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37720208)

  • 1. Research progress on the mechanism of cholesterol-25-hydroxylase in intestinal immunity.
    Zhong G; He C; Wang S; Lin C; Li M
    Front Immunol; 2023; 14():1241262. PubMed ID: 37720208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
    Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research progress of targeting macrophage surface receptors in the treatment of inflammatory bowel disease].
    Zhang L; Xu H; Wang T; Wang B; Zhang S; Zhang D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 May; 38(5):460-465. PubMed ID: 35603655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases.
    Kayama H; Takeda K
    Eur J Immunol; 2023 Aug; 53(8):e2249866. PubMed ID: 37191284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A practical guide to chronic inflammatory bowel disease].
    Salvador Nunes L; Greuter T; Henchoz S; Schoepfer A
    Rev Med Suisse; 2021 Sep; 17(748):1448-1452. PubMed ID: 34468095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Update on Herbal Products for the Management of Inflammatory Bowel Disease.
    Arya H; Dass R; Chopra B; Kriplani P; Deswal G; Singh Grewal A; Dhingra AK; Kumar S
    Antiinflamm Antiallergy Agents Med Chem; 2023; 22(1):1-9. PubMed ID: 37497699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical roles of G protein-coupled receptors in regulating intestinal homeostasis and inflammatory bowel disease.
    Feng Z; Sun R; Cong Y; Liu Z
    Mucosal Immunol; 2022 May; 15(5):819-828. PubMed ID: 35732818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
    Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
    Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic insights on the metabolism in inflammatory bowel disease.
    Pisani LF; Moriggi M; Gelfi C; Vecchi M; Pastorelli L
    World J Gastroenterol; 2020 Feb; 26(7):696-705. PubMed ID: 32116417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal microbiota and ulcerative colitis.
    Ohkusa T; Koido S
    J Infect Chemother; 2015 Nov; 21(11):761-8. PubMed ID: 26346678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Cell Landscaping Reveals Distinct Immune Signatures of Inflammatory Bowel Disease.
    Bai X; Liu W; Chen H; Zuo T; Wu X
    Front Immunol; 2022; 13():861790. PubMed ID: 35371090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling Inflammatory Bowel Disease by Intestinal Organoids.
    Di Giorgio C; Roselli R; Biagioli M; Bordoni M; Ricci P; Zampella A; Distrutti E; Donini A; Fiorucci S
    Recent Adv Inflamm Allergy Drug Discov; 2023; 17(1):39-53. PubMed ID: 36411558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets.
    Stefanelli T; Malesci A; Repici A; Vetrano S; Danese S
    Curr Drug Targets; 2008 May; 9(5):413-8. PubMed ID: 18473770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ulcerative colitis].
    Lopetuso L; Gasbarrini A
    Recenti Prog Med; 2016 Jun; 107(6):297-308. PubMed ID: 27362722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored.
    Zhu M; Song Y; Xu Y; Xu H
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis?
    Wen Z; Fiocchi C
    Clin Dev Immunol; 2004; 11(3-4):195-204. PubMed ID: 15559364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.